Lupin informs about press release

21 Nov 2023 Evaluate

Lupin has informed that it enclosed a Press release regarding receipt of US FDA approval for the Company’s Abbreviated New Drug Application for Pitavastatin Tablets, 1 mg, 2 mg, and 4 mg, to market a generic equivalent of Livalo Tablets, 1 mg, 2 mg, and 4 mg, of Kowa Company. 

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2100.25 -11.75 (-0.56%)
01-Jan-2026 13:43 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1716.90
Dr. Reddys Lab 1249.35
Cipla 1500.25
Zydus Lifesciences 913.15
Lupin 2100.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×